Segment Information (Details)	3 Months Ended								9 Months Ended	10 Months Ended	12 Months Ended
	Dec. 31, 2016 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2016 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Sep. 30, 2015 USD ($)	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Sep. 30, 2016 segment	Dec. 31, 2014 USD ($)	Dec. 31, 2016 USD ($) segment	Dec. 31, 2015 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment									2		2
Total revenue	$ 298,904	$ 599,074	$ 112,685	$ 0						$ 0	$ 1,010,663	$ 0
Interest income, net	$ 84,232	$ 97,726	$ 107,818	$ 103,333	$ 37,631	$ 14,637	$ 16,183	$ 3,577		18,946	393,109	72,028
Loss from operations										8,029,806	39,886,232	29,213,658
Operating Segments | Consumer Operations
Segment Reporting Information [Line Items]
Total revenue										0	1,010,663	0
Interest income, net										0	0	0
Loss from operations										898,504	10,023,137	7,892,584
Operating Segments | Drug Development
Segment Reporting Information [Line Items]
Total revenue										0	0	0
Interest income, net										0	0	0
Loss from operations										4,003,911	19,620,338	12,224,692
Corporate
Segment Reporting Information [Line Items]
Total revenue										0	0	0
Interest income, net										18,946	393,109	72,028
Loss from operations										$ 3,127,391	$ 10,242,757	$ 9,096,382